You can’t move forward until you see where you’ve been! Dr. Harvey Klein has seen massive changes in Transfusion Medicine, and he joins us to look at the past, present, and future!
Harvey does not just live in the past, however! He has published several articles in regard to our present and future state in transfusion medicine that have gotten lots of recent attention (see links to these articles below), and he’s willing to stir up a little trouble if he needs to! In the “Present” and “Future” portions of the interview, Dr. Klein shares his views on some of the accomplishments and challenges facing Transfusion Medicine. His thoughts may open your eyes to things you never knew! You do NOT want to miss this one!
About My Guest:
Harvey G. Klein graduated magna cum laude from Harvard College and earned his medical degree from Johns Hopkins School of Medicine. After an internship, residency and fellowship in hematology at Hopkins, Dr. Klein came to the National Institutes of Health in 1973, becoming chief of the Clinical Center’s Department of Transfusion Medicine in 1984.
Dr. Klein is known nationally and internationally for his expertise in blood transfusion. He is widely published on such topics as transfusion-transmitted disease, management of immunosuppressive effects of blood transfusion, blood storage, and the impact of biotechnology on transfusion medicine. He coauthored the eleventh edition of Mollison’s textbook, “Blood Transfusion in Clinical Medicine,” and has held editorial roles with several publications, including Blood, Transfusion, Transfusion Medicine Reviews, and the Journal of Clinical Apheresis.
Dr. Klein, a former AABB president, was chosen as the 2017 Bernard Fantus Lifetime Achievement Award winner by the AABB, recognizing his “numerous, outstanding contributions to the scientific basis and/or clinical practice of blood banking and transfusion medicine during the preceding 50 years.”
DISCLAIMER: The opinions expressed on this episode are those of my guest and I alone, and do not reflect those of the organizations with which either of us is affiliated. Neither Dr. Klein nor I have any relevant financial disclosures.
- Dr. Klein and colleagues on concerns regarding modern RBC transfusion decisions: Klein HG et al. Red Blood Cell Transfusion: Precision vs Imprecision Medicine. JAMA 2015;314(15):1557-1558.
- Are those “restrictive” vs. “liberal” strategy studies missing something? Deans KJ et al. The relevance of practice misalignments to trials in transfusion medicine. Vox Sanguinis 2010;99:16–23.
- Can we keep going with the same “blood is a commodity” model in the United States? Klein HG et al. Crisis in the Sustainability of the U.S. Blood System. N Engl J Med 2017;377:1485-1488.
- More Opinions on the U.S. Blood System: Responses to Dr. Klein and colleague’s article from the NEJM (N Engl J Med 2018;378:305-306)